rony dev

Associate Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Rony Dev is an Associate Professor at the University of Texas MD Anderson Cancer Center. His research primarily focuses on the psychological burden and nutritional impact symptoms in cancer patients, as highlighted in his recent articles. He has contributed significantly to the understanding of malnutrition risk, coping strategies, and opioid management among oncology patients. Dr. Dev's work also explores the perception of integrated electronic health records and substance use among patients dealing with cancer-related pain.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Joseph A. Arthur

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Kimberson Tanco

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ahsan Azhar

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Akhila Reddy

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

rony dev

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

International Survey on Consensus Definition on Nutrition Impact Symptoms in Patients with Cancer

Malnutrition Risk and the Psychological Burden of Anorexia and Cachexia in Patients With Advanced Cancer

Perceptions Toward Naloxone Among Patients With Cancer Receiving Opioids

Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome

Coping Strategies and Associated Symptom Burden Among Patients With Advanced Cancer

Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study

Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study

Oncology patients' perception of physicians who use an integrated electronic health record (EHR) during clinic visits: PRIME-EHR double-blind, randomized controlled trial

Random urine drug testing among patients receiving opioid therapy for cancer pain

Alcohol, Tobacco, and Substance Use and Association with Opioid Use Disorder in Patients with Non-malignant and Cancer Pain: a Review

Collaborators (4)

Joseph A. Arthur

Kimberson Tanco

Ahsan Azhar

Akhila Reddy

Make your next move.